Inhibitory Activity of Tryptanthrin on Prostaglandin and Leukotriene Synthesis
- 21 October 2002
- journal article
- research article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 68 (10) , 875-880
- https://doi.org/10.1055/s-2002-34922
Abstract
The indolo[2,1-b]quinazoline alkaloid tryptanthrin has previously been identified as the cyclooxygenase-2 (COX-2) inhibitory principle in the extract ZE550 prepared from the medicinal plant Isatis tinctoria (Brassicaceae). We here investigated the potential inhibitory activity of tryptanthrin and ZE550 on COX-2, COX-1 in cellular and cell-free systems. A certain degree of selectivity towards COX-2 was observed when COX-1-dependent formation of thromboxane B2 (TxB2) in HEL cells and COX-2-dependent formation of 6-ketoprostaglandin F1 α (6-keto-PGF1 α) in Mono Mac 6 and RAW 264.7 cells were compared. Preferential inhibition of COX-2 by two orders of magnitude was found in phorbol myristate acetate (PMA) activated bovine aortic coronary endothelial cells (BAECs). Assays with purified COX isoenzymes from sheep confirmed the high selectivity towards COX-2. The leukotriene B4 (LTB4) release from calcium ionophore-stimulated human granulocytes (neutrophils) was used as a model to determine 5-lipoxygenase (5-LOX) activity. Tryptanthrin and the extract ZE550 inhibited LTB4 release in a dose dependent manner and with a potency comparable to that of the clinically used 5-LOX inhibitor zileuton.Keywords
This publication has 0 references indexed in Scilit: